Search Bar & Filters
Found 3 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the effects of experimental drugs pozelimab and cemdisiran in adults aged 50 to 85 with Geographic Atrophy GA caused by Age-related Macular Degeneration AMD, a condition affecting central vision. The study aims to compare the progression rate of GA in patients treated with cemdisiran alone, pozelimab combined with cemdisiran, and a placebo, while also examining side effects, drug levels in the blood, and immune responses to the drugs. Participants are randomly assigned to one of three groups pozelimab plus cemdisiran, cemdisiran alone, or placebo. All treatments are given by subcutaneous injection. The study is double-masked and placebo-controlled, lasting up to 104 weeks for key outcome measures, with extended safety monitoring up to 296 weeks. The trial includes multiple visits for evaluations and treatments over this period. During the study, participants undergo detailed eye imaging using Fundus Autofluorescence to measure GA lesion growth, assessments of visual acuity, and contrast sensitivity tests at weeks 52 and 104. Blood samples are collected to measure drug concentrations and immune responses, including antibodies against the drugs. Safety is monitored throughout the study and during extended follow-up. Participants adherence to clinic visits and vaccinations is required for participation.
Actively Recruiting
Researchers are evaluating the use of the Apple Vision Pro device as an additional visualization and information display tool during ophthalmic surgeries such as cataract surgery. This prospective, observational, single-arm study aims to assess the feasibility and usability of this head-mounted spatial computing device in the surgical setting without altering the standard of care. Adult patients undergoing standard intraocular surgeries will have their procedures performed routinely, while the attending surgeon may optionally use the Apple Vision Pro alongside traditional microscopes and displays. Approximately 40 to 70 surgeries will be observed across multiple sites, focusing on how the device supports surgical visualization and information access. Participants will be monitored during their surgeries, with data collected intraoperatively and immediately after surgery from surgical records and surgeon questionnaires. The study will review continuity of care and questionnaire outcomes over one year, with no experimental procedures performed on patients. This observational approach allows careful assessment of the devices practical use without impacting patient treatment.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating a clinical decision support system developed by Singula Health for use in primary care settings. This observational pilot study focuses on adult patients scheduled for routine primary care visits, aiming to assess the systems ability to generate structured summaries called Companion Briefs. These Briefs are designed to help clinicians by organizing patient self-reported information about behavioral health symptoms, anxiety, and depression. The study also seeks to understand how useful and acceptable the Briefs are to both clinicians and patients. Before their visit, patients complete a self-report assessment on a personal device, which includes validated screening tools and structured questions relevant to their health. The system processes these responses to create an AI-generated draft Companion Brief. This draft is reviewed by the Principal Investigator for accuracy and safety before being shared with the treating clinician. The clinician receives the Brief prior to the routine visit but retains full control over clinical decisions. No treatment or intervention is assigned as part of the study. Participants complete the pre-visit assessment and their data are used to measure the systems performance, including the timely production and delivery of Companion Briefs, clinician feedback on their utility, and patient acceptance and completion rates. Safety flags generated by the system and any corrections made to the AI reports are also monitored. The study includes periodic clinician surveys during active enrollment and measures various performance and usability outcomes over a short timeframe around the visit. Total participation involves completing the assessment and providing feedback during routine care, without additional interventions.